MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME – Talk Bio

Actionable Insights Powered by AI

Johnson & Johnson to Appeal $150 Million Verdict in HIV Meds Off-Label Marketing Case

10 months ago talkbio0Tagged appeal, HIV, Johnson and Johnson, MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME, Off-Label Marketing, verdict

Johnson & Johnson, HIV Meds, Off-Label Marketing, Appeal, $150 Million Verdict